{"schema_version":"secwatch.filing_event.v1","accession":"0001729149-22-000072","form_type":"8-K","ticker":"VMD","cik":"0001729149","company_name":"VIEMED HEALTHCARE, INC.","filed_at":"2022-08-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:56.837171+00:00","generated_at":"2026-06-24T06:01:37.807957+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Viemed Healthcare Q2 2022 core revenue $33.1M record, up 26% YoY; adjusted EBITDA $6.5M","bullets":["Q2 core net revenues $33.1M (record); total revenues including COVID-19 services $33.3M.","Adjusted EBITDA of $6.5M for Q2 2022 and $13.7M for six months ended June 30, 2022.","Ventilator patient count 8,837, up 9% YoY; highest quarterly growth since Q2 2019.","Repurchased 1,350,567 shares at avg $5.18 per share, total cost $7.0M.","Medicare overpayment exposure reduced to $1.1M after reconsideration; appeals filed."],"urls":{"canonical":"https://secwatch.observer/filing/0001729149-22-000072","json":"https://secwatch.observer/filing/0001729149-22-000072.json","markdown":"https://secwatch.observer/filing/0001729149-22-000072.md","text":"https://secwatch.observer/filing/0001729149-22-000072.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1729149/000172914922000072/0001729149-22-000072-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1729149/000172914922000072/vmd-20220802.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T06:01:37.807957+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}